To include your compound in the COVID-19 Resource Center, submit it here.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd., GlaxoSmithKline deal

GlaxoSmithKline acquired Shenzhen's 51% stake in the

Read the full 78 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE